Obtained board''s approval for shift in registered office from Andhra Pradesh to Maharashtra subject to shareholders and regulatory''s approval

CCME Global Limited (formerly known as Genesis IBRC India Limited) CIN: L46909AP1992PLC107068 Regd. Off: Flat No: 401, VVN Residency, 40-A, Ashok Nagar, Eluru, Andhra Pradesh 534002 Corp. Office: 501, 5th Floor, A Wing, Navkar Chambers, Opp. Star Plus, Marol Naka, Andheri Kurla Road, Andheri East, Mumbai - 400059 Tel: 08829-256599, Website: www.genesisiil.com, Email: csgenesisiil@gmail.com Date: August 29, 2026 Department of Corporate Services (DSC-CRD) Bombay Stock Exchange Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai – 400001 Subject: Outcome of Board Meeting held on Saturday, 29th day of August, 2026 pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. Ref.: CCME GLOBAL LIMITED (formerly known as GENESIS IBRC INDIA LIMITED, Scrip Code: 514336, ISIN: INE194N01016. Dear Sir/Madam, In furtherance to our intimation under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”) about the board meeting and in pursuant to Regulation 30 of the SEBI LODR Regulations, read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/2025 /3762 dated January 30, 2026, we would like to inform you that the Board of Directors of CCME Global Limited {formerly known as Genesis IBRC India Limited} (“Company”) in their meeting held today, i.e., Saturday, 29th day of August, 2026, have inter alia, considered, recommended, and approved the following matters: 1. Ratified the appointment of Registered Valuer to determine the fair price of the Equity Shares / Convertible Securities of the Company proposed to be issued on a preferential basis. 2. Approved draft valuation report received from Registered Valuer who has determined the price of the Company for the proposed issue and allotment of securities on preferential basis. 3. Took note of report on valuation of Cash & Carry Middle East FZCO received from Akasam Consulting Private Limited, SEBI registered Category-I Merchant Banker. 4. Took note of report on valuation of Interlink Distribution LLC received from Akasam Consulting Private Limited, SEBI registered Category-I Merchant Banker. 5. Approved acquisition of more than 50% share capital of Cash & Carry Middle East FZCO through (a) share swap (i.e. non-cash consideration basis), for the total consideration of about INR 112,72,50,000 (Indian Rupees One Hundred Twelve Crore Seventy-Two Lakhs Fifty Thousand Only) and Share Swap Agreement entered between the Company, CCME UAE and shareholders of CCME UAE; and (b) Purchase of shares from existing shareholders of CCME UAE through cash. Page 1 of 18 CCME Global Limited (formerly known as Genesis IBRC India Limited) CIN: L46909AP1992PLC107068 Regd. Off: Flat No: 401, VVN Residency, 40-A, Ashok Nagar, Eluru, Andhra Pradesh 534002 Corp. Office: 501, 5th Floor, A Wing, Navkar Chambers, Opp. Star Plus, Marol Naka, Andheri Kurla Road, Andheri East, Mumbai - 400059 Tel: 08829-256599, Website: www.genesisiil.com, Email: csgenesisiil@gmail.com 6. Approved acquisition of 52% of share capital of Interlink Distribution LLC through share swap (i.e. non-cash consideration basis), for the total consideration of about INR 20,34,22,490 (Indian Rupees Twenty Crore Thirty-Four Lakhs Twenty-Two Thousand Four Hundred Ninety Only) Share Swap Agreement entered between the Company, Interlink and shareholders of Interlink. Disclosure of Information pursuant to Regulation 30 read with Part A of Schedule III of SEBI (LODR) Regulations, 2015 read with SEBI Circulars issued from time to time for matters in 5 and 6 above are enclosed as Annexure A. 7. Approved, subject to shareholders and regulatory authorities approval to create, offer, issue and allot in one or more tranches on preferential issue basis and related matters in below manner: (a) up to 1,80,00,000 (One Crore Eighty Lakhs) equity shares share of the Company of face value of INR 10/- (Indian Rupees Ten Only) each (‘Subscription Shares’) at INR 10 (Indian Rupees Ten Only) per equity share, payable in cash (‘Share Issue Price’), aggregating up to INR 18,00,00,000 (Indian Rupees Eighteen Crores Only); (b) up to 11,27,25,000 (Eleven Crore Twenty-Seven Lakhs Twenty-Five Thousand) fully paid-up equity shares of the Company of face value of INR 10/- (Indian Rupees Ten Only) each (“Swap 1 Shares”) at INR 10 (Indian Rupees Ten Only) per equity share, aggregating to INR 112,72,50,000 (Indian Rupees One Hundred Twelve Crore Seventy-Two Lakhs Fifty Thousand Only) to shareholders of Cash & Carry Middle East FZCO (“CCME UAE”) for acquisition of 45% of CCME UAE’s share capital; and (c) up to 2,03,42,249 (Two Crore Three Lakhs Forty Two Thousand Two Hundred Forty-Nine) fully paid-up equity shares of the Company of face value of INR 10/- (Indian Rupees Ten Only) each (“Swap 2 Shares”) at INR 10 (Indian Rupees Ten Only) per equity share, aggregating to INR 20,34,22,490 (Indian Rupees Twenty Crore Thirty-Four Lakhs Twenty-Two Thousand Four Hundred Ninety Only) to shareholders of Interlink Distribution LLC (“Interlink”) for acquisition of 52% of Interlink’s share capital. Disclosure of Information pursuant to Regulation 30 read with Part A of Schedule III of SEBI (LODR) Regulations, 2015 read with SEBI Circulars issued from time to time for matters in 7 above is enclosed as Annexure B. 8. Approved Relevant Date, in terms of provisions of the SEBI (ICDR) Regulations, 2018 for the preferential issue as Friday, August 28, 2026. 9. Approved constitution of Preferential Issue Committee (“PIC”) for preferential issue purpose and authorised PIC to deal with the matters related to the said preferential issue. 10. Approved increased in Authorised Share Capital of the Company and consequently amendment in Clause V/5 of the Company’s Memorandum of Association. Page 2 of 18 CCME Global Limited (formerly known as Genesis IBRC India Limited) CIN: L46909AP1992PLC107068 Regd. Off: Flat No: 401, VVN Residency, 40-A, Ashok Nagar, Eluru, Andhra Pradesh 534002 Corp. Office: 501, 5th Floor, A Wing, Navkar Chambers, Opp. Star Plus, Marol Naka, Andheri Kurla Road, Andheri East, Mumbai - 400059 Tel: 08829-256599, Website: www.genesisiil.com, Email: csgenesisiil@gmail.com 11. Approved sub-Division / Split of 1 (One) Equity Share of face value of INR 10 (Indian Rupees Ten Only) each, into fully paid up 10 (Ten) equity shares of face value of INR 1 (Indian Rupee One Only) each, and consequential alteration of the Capital Clause i.e., Clause V/5 of the Company’s Memorandum of Association, both subject to the approval of the Members of the Company and other regulatory / statutory approvals as may be required. The record date for the sub-division of equity shares shall be decided by the Board and will be intimated to the stock exchanges after receipt of approval of the members. Disclosure of Information pursuant to Regulation 30 read with Part A of Schedule III of SEBI (LODR) Regulations, 2015 read with SEBI Circulars issued from time to time for matters in 11 above is enclosed as Annexure C. 12. Approved appointment of Monitoring Agence for the preferential issue. 13. Approved shift in registered office of the Company from the State of Andhra Pradesh to the State of Maharashtra. 14. Recommended the regularisation of Ms. Ami Oza (DIN: 11385775) as an Independent Non-Executive Director of the Company to the Shareholders in the ensuing Annual General Meeting of the Company. 15. Approved Directors Report along with related annexures of the Company for the Financial Year ended 2025-2026; 16. Approved the closure of Register of Members and Share Transfer Books of the Company for AGM purpose from Wednesday, September 23, 2026, to Tuesday, September 29, 2026. 17. Approved the cut-off date to record the entitlement of shareholders to cast the votes electronically. 18. Approved convening of the 34th (Thirty-Fourth) Annual General Meeting (“AGM”) of the Company for the financial year ended 31st March, 2026 on Tuesday, Se [Showing first 8,000 characters — download PDF for full document]